Artwork

Konten disediakan oleh Molecule. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Molecule atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Player FM - Aplikasi Podcast
Offline dengan aplikasi Player FM !

Revolutionizing Drug Discovery with AI - The Arctoris Approach with Martin-Immanuel Bittner

33:32
 
Bagikan
 

Manage episode 366173329 series 3394247
Konten disediakan oleh Molecule. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Molecule atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.

Welcome to another episode of the DeSci Podcast. Today, we had the privilege of having Dr. Martin-Immanuel Bittner as our guest. He is the CEO of Arctoris, which is the world's first fully automated platform for drug discovery, focused on accelerating the drug discovery process.

In this episode, we explore a variety of fascinating topics related to drug discovery. Dr. Bittner shares insights on the story behind building Arctoris and its mission to accelerate the drug discovery process. We also talk about how the drug development process has evolved over the years and the need to automate drug discovery research.

Other topics discussed were challenges stemming from the lack of rigorous funding in biotech, common misconceptions about automation, and many more.

Please feel free to navigate through any of the topics discussed in the podcast using the timestamps below.

____

⭐ Timestamps:

0:38 Intro

1:18 About Arctoris

2:52 What drove your interests in building Arctoris

4:23 Learnings from running Arctoris

5:53 What area needs more focus

8:03 Common misconceptions about automation

10:01 Flexibility in automation

13:44 Underexploited areas

16:09 Antibiotic resistance problem

17:58 Funding structures for Biotech companies

20:15 Investing in Biotech

22:38 The private sector and Academia

25:00 Changing beliefs on the need of automation in drug discovery

27:08 Contentious issues within your field

29:06 Implicit knowledge in drug discovery

____

If you prefer listening to podcasts on audio apps, feel free to search for "The DeSci Podcast" on Spotify, Google Podcasts & Apple Podcasts. You'll also find all links to the podcast apps below.

If you want to join us on the show as a speaker or have guest ideas, please shoot us a mail at podcast@molecule.to

Special thanks to:

Lea Degen (host): https://twitter.com/lealeata

Martin: https://www.linkedin.com/in/martinimmanuelbittner/?originalSubdomain=uk

____

Let's connect:

Website: https://bit.ly/3d6nh2C

Twitter: https://twitter.com/Molecule_dao

Discord: https://discord.com/invite/moleculedao

  continue reading

38 episode

Artwork
iconBagikan
 
Manage episode 366173329 series 3394247
Konten disediakan oleh Molecule. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Molecule atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.

Welcome to another episode of the DeSci Podcast. Today, we had the privilege of having Dr. Martin-Immanuel Bittner as our guest. He is the CEO of Arctoris, which is the world's first fully automated platform for drug discovery, focused on accelerating the drug discovery process.

In this episode, we explore a variety of fascinating topics related to drug discovery. Dr. Bittner shares insights on the story behind building Arctoris and its mission to accelerate the drug discovery process. We also talk about how the drug development process has evolved over the years and the need to automate drug discovery research.

Other topics discussed were challenges stemming from the lack of rigorous funding in biotech, common misconceptions about automation, and many more.

Please feel free to navigate through any of the topics discussed in the podcast using the timestamps below.

____

⭐ Timestamps:

0:38 Intro

1:18 About Arctoris

2:52 What drove your interests in building Arctoris

4:23 Learnings from running Arctoris

5:53 What area needs more focus

8:03 Common misconceptions about automation

10:01 Flexibility in automation

13:44 Underexploited areas

16:09 Antibiotic resistance problem

17:58 Funding structures for Biotech companies

20:15 Investing in Biotech

22:38 The private sector and Academia

25:00 Changing beliefs on the need of automation in drug discovery

27:08 Contentious issues within your field

29:06 Implicit knowledge in drug discovery

____

If you prefer listening to podcasts on audio apps, feel free to search for "The DeSci Podcast" on Spotify, Google Podcasts & Apple Podcasts. You'll also find all links to the podcast apps below.

If you want to join us on the show as a speaker or have guest ideas, please shoot us a mail at podcast@molecule.to

Special thanks to:

Lea Degen (host): https://twitter.com/lealeata

Martin: https://www.linkedin.com/in/martinimmanuelbittner/?originalSubdomain=uk

____

Let's connect:

Website: https://bit.ly/3d6nh2C

Twitter: https://twitter.com/Molecule_dao

Discord: https://discord.com/invite/moleculedao

  continue reading

38 episode

Semua episode

×
 
Loading …

Selamat datang di Player FM!

Player FM memindai web untuk mencari podcast berkualitas tinggi untuk Anda nikmati saat ini. Ini adalah aplikasi podcast terbaik dan bekerja untuk Android, iPhone, dan web. Daftar untuk menyinkronkan langganan di seluruh perangkat.

 

Panduan Referensi Cepat